Dosimetric advantage of combining 131I-MIBG and 90Y-DOTATOC

Abstract

Peer reviewed

David Bushnell, Mark Madsen, Tom O'Dorisio, Yusuf Menda, Beth Schmitt and Sue O'Dorisio

Regulatory peptides, Vol.164(1), pp.11-11

09/09/2010

DOI: 10.1016/j.regpep.2010.07.031

View Online

Title: Subtitle: Dosimetric advantage of combining 131I-MIBG and 90Y-DOTATOC
Creators: David Bushnell - University of Iowa
Mark Madsen - University of Iowa
Tom O'Dorisio - University of Iowa Hospitals and Clinics
Yusuf Menda - University of Iowa
Beth Schmitt - United States Department of Veterans Affairs
Sue O'Dorisio - University of Iowa
Resource Type: Abstract
Publication Details: Regulatory peptides, Vol.164(1), pp.11-11
Publisher: Elsevier B.V
DOI: 10.1016/j.regpep.2010.07.031
ISSN: 0167-0115
eISSN: 1873-1686
Language: English
Date published: 09/09/2010
Academic Unit: Radiology; Radiation Oncology; Stead Family Department of Pediatrics; Endocrinology and Metabolism; Internal Medicine
Record Identifier: 9984314282302771

16 Record Views